Giancarlo Castellano

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

A Reassessment of the Validity of the Routine Lymph2Cx Assay for the Cell-of-Origin Assignment of Diffuse Large B-Cell Lymphoma.

A Reassessment of the Validity of the Routine Lymph2Cx Assay for the Cell-of-Origin Assignment of Diffuse Large B-Cell Lymphoma.

Journal: European journal of haematology

Published: May 19, 2026

SPINK2 silencing suppresses leukemic proliferation and restores myeloid commitment via MECOM downregulation in acute myeloid leukaemia.

SPINK2 silencing suppresses leukemic proliferation and restores myeloid commitment via MECOM downregulation in acute myeloid leukaemia.

Journal: Cell death discovery

Published: October 14, 2025

Genomics Define Malignant Transformation in Myeloma Precursor Conditions.

Genomics Define Malignant Transformation in Myeloma Precursor Conditions.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 08, 2025

The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenocarcinoma.

The absence of IL17A favours cytotoxic cell function and improves antigen-specific immunotherapies in pancreatic adenocarcinoma.

Journal: Clinical and translational medicine

Published: April 08, 2025

Discovery and validation of frameshift-derived neopeptides in Lynch syndrome: paving the way for novel cancer prevention strategies.

Discovery and validation of frameshift-derived neopeptides in Lynch syndrome: paving the way for novel cancer prevention strategies.

Journal: Journal for immunotherapy of cancer

Published: March 23, 2025

Frequency of driver oncogenic alterations in NSCLC and estimated indoor radon exposure in Europe (RADON EUROPE study).

Frequency of driver oncogenic alterations in NSCLC and estimated indoor radon exposure in Europe (RADON EUROPE study).

Journal: Therapeutic advances in medical oncology

Published: March 07, 2025

KPC pancreatic cancer cells are a novel immunocompetent murine model supporting human adenovirus replication and tumor oncolysis.

KPC pancreatic cancer cells are a novel immunocompetent murine model supporting human adenovirus replication and tumor oncolysis.

Journal: Molecular therapy. Oncology

Published: August 01, 2024

Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changes.

Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changes.

Journal: Blood

Published: July 19, 2024

Aberrant single-cell phenotype and clinical implications of genotypically defined polyclonal plasma cells in myeloma.

Aberrant single-cell phenotype and clinical implications of genotypically defined polyclonal plasma cells in myeloma.

Journal: Blood

Published: June 05, 2024

Inference of genomic lesions from single-cell RNA-seq in myeloma improves functional intraclonal and interclonal analysis.

Inference of genomic lesions from single-cell RNA-seq in myeloma improves functional intraclonal and interclonal analysis.

Journal: Blood advances

Published: December 13, 2023

Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma.

Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma.

Journal: Leukemia

Published: June 01, 2022

Remission of obesity and insulin resistance is not sufficient to restore mitochondrial homeostasis in visceral adipose tissue.

Remission of obesity and insulin resistance is not sufficient to restore mitochondrial homeostasis in visceral adipose tissue.

Journal: Redox biology

Published: March 16, 2022

Showing 1-12 of 56

Last Updated: 09/26/2026